https://www.genengnews.com/news/janssen-ends-collaboration-with-geron-to-develop-cancer-candidate-imetelstat/ What if any was Jansen responsibility here to report ? & why has lead Doc s heading up Imetelstat left to go work for Geron ? And does FDA just give out fast tracks Sept 2019 to Geron , and last can Geron focus have been shifted to overall survival data given data in studies & changes FDA to poss consider same ? Thanks again